BioCentury
ARTICLE | Company News

Affitech names Burns CEO

September 2, 2009 1:33 AM UTC

Antibody company Affitech A/S (CSE:AFFI) hired Robert Burns as CEO. Previously, Burns was CEO of Celldex Therapeutics Inc. (NASDAQ:CLDX). He replaces Achim Kaufhold, who left the company to pursue oth...